<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03843164</url>
  </required_header>
  <id_info>
    <org_study_id>7311</org_study_id>
    <nct_id>NCT03843164</nct_id>
  </id_info>
  <brief_title>Lung Nodule Characterization by Artificial Intelligence Techniques</brief_title>
  <acronym>CARANOD-IA</acronym>
  <official_title>Lung Nodule Characterization by Artificial Intelligence Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Management of incidental lung nodule is difficult and mainly based on simple morphometric
      characteristics such as maximum size and shape. Radiomics could play a role in simplifying
      this management by orientating towards a benign or a malignant origin, by comparing advanced
      characteristics to a large database of lung nodules.

      The primary purpose is to evaluate the performances of a novel tool based on radiomics to
      characterize incidental lung nodules, discovered on computed tomography.

      The secondary objectives are:

        -  to evaluate the variation in the performances of the software based on various technical
           aspects of the CT, such as radiation dose, reconstruction algorithm, type of scanner,…

        -  to compare the performances of this software to those of expert readers,

        -  to analyze the potential impact of this software on patient's management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the performances of a novel tool based on radiomics to characterize incidental lung nodules, discovered on computed tomography.</measure>
    <time_frame>he period from January 1st, 2012 to October 01, 2018 will be examined</time_frame>
    <description>The study concerns patients who performed a chest CT scan at Strasbourg University Hospitals between 01/01/2012 and 01/10/2018</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Incidental Lung Nodule</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a chest CT acquired between Jan 1 2012 and Oct 1 2018 at the Strasbourg
        University Hospital;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient (at least 18 years old);

          -  With a chest CT acquired between Jan 1 2012 and Oct 1 2018 at the Strasbourg
             University Hospital;

          -  CT being available over the PACS and exhibiting at least one lung nodule;

          -  Patient having given its authorization for the exploitation of his medical data for
             this research.

        Exclusion Criteria:

          -  Patient having expressed direct opposition to participation in this study;

          -  Patient under juridical protection;

          -  Patient under tutelage or guardianship.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Mickaël OHANA, MD</last_name>
    <phone>33 3 69 55 11 17</phone>
    <email>mickael.ohana@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aissam LABANI, MD</last_name>
    <phone>33 3 69 55 11 17</phone>
    <email>aissam.labani@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Radiologie B - NHC</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mickaël OHANA, MD</last_name>
      <phone>33 3 69 55 11 17</phone>
      <email>mickael.ohana@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aissam LABANI, MD</last_name>
      <phone>33 3 69 55 11 17</phone>
      <email>aissam.labani@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Mickaël OHANA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aissam LABANI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Alexis AUTRUSSEAU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 13, 2019</study_first_submitted>
  <study_first_submitted_qc>February 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Solitary Pulmonary Nodule</keyword>
  <keyword>Multidetector Computed Tomography</keyword>
  <keyword>Artificial Intelligence</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

